LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $1,007,301

Key CONT_AWD_75N91023F00009_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 66 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91023F00009_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91023F00009_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:56:22Z

Content hash 991142bd84204f25f6ef39e5e38fdcf60017771fe6c0cfc09959303c3c795b7e

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$1,007,301	first version	June 28, 2023	July 1, 2026	2026-09-05T00:56:22Z	historical sweep	`991142bd8420`

Archived copy

https://web.archive.org/web/20261017150829/https://www.usaspending.gov/award/CONT_AWD_75N91023F00009_7529_75N91019D00024_7529 captured by this system, October 17, 2026

What the amount is made of

4 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-09, when USAspending reported a total obligation of $1,007,301.

Action date	Modification	Type	Obligated	Description as recorded
July 1, 2026	P00003	OTHER ADMINISTRATIVE ACTION	no money	INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST
September 20, 2024	P00002	CHANGE ORDER	+$564,711	INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST
July 11, 2023	P00001	OTHER ADMINISTRATIVE ACTION	no money	INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST
June 28, 2023	base	not on file	+$442,590	INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST

Last refreshed November 4, 2026 at 2:31 PM UTC.